X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (29795) 29795
Publication (3559) 3559
Book Review (307) 307
Book Chapter (136) 136
Book / eBook (47) 47
Conference Proceeding (43) 43
Dissertation (25) 25
Newspaper Article (6) 6
Data Set (5) 5
Government Document (2) 2
Magazine Article (2) 2
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (21040) 21040
index medicus (19028) 19028
animals (17457) 17457
mice (13512) 13512
oncology (11939) 11939
cancer (11138) 11138
cell line, tumor (10841) 10841
xenograft model antitumor assays (10176) 10176
female (8877) 8877
apoptosis (6501) 6501
antineoplastic agents - pharmacology (5990) 5990
tumors (5904) 5904
mice, nude (5773) 5773
antitumor-activity (5739) 5739
male (5440) 5440
chemotherapy (4993) 4993
pharmacology & pharmacy (4393) 4393
cell proliferation - drug effects (4322) 4322
research (3923) 3923
apoptosis - drug effects (3890) 3890
care and treatment (3768) 3768
antitumor activity (3573) 3573
expression (3394) 3394
cancer therapies (3369) 3369
mice, inbred balb c (3368) 3368
health aspects (3314) 3314
drug screening assays, antitumor (3187) 3187
cytotoxicity (3134) 3134
in-vivo (2988) 2988
article (2973) 2973
immunotherapy (2958) 2958
therapy (2943) 2943
proteins (2891) 2891
in-vitro (2839) 2839
antineoplastic agents - therapeutic use (2832) 2832
medicine (2699) 2699
analysis (2663) 2663
medicine, research & experimental (2658) 2658
anticancer properties (2646) 2646
metastasis (2603) 2603
cells (2551) 2551
breast cancer (2527) 2527
biochemistry & molecular biology (2515) 2515
research article (2434) 2434
cell survival - drug effects (2420) 2420
multidisciplinary sciences (2389) 2389
cell biology (2335) 2335
kinases (2318) 2318
nanoparticles (2235) 2235
dose-response relationship, drug (2162) 2162
gene expression (2139) 2139
antineoplastic agents - chemistry (2138) 2138
drugs (2138) 2138
inhibition (2108) 2108
tumor cells, cultured (2091) 2091
toxicity (2077) 2077
neoplasms - drug therapy (2065) 2065
disease models, animal (2031) 2031
drug delivery systems (2031) 2031
immunology (2014) 2014
cell proliferation (1967) 1967
growth (1919) 1919
breast-cancer (1890) 1890
xenografts (1870) 1870
treatment outcome (1864) 1864
antitumor agents (1850) 1850
cell cycle (1850) 1850
science (1843) 1843
antineoplastic agents - administration & dosage (1828) 1828
drug therapy (1827) 1827
activation (1807) 1807
angiogenesis (1790) 1790
drug synergism (1789) 1789
genetic aspects (1764) 1764
chemistry, medicinal (1707) 1707
antitumor immunity (1703) 1703
signal transduction (1696) 1696
signal transduction - drug effects (1679) 1679
mice, scid (1627) 1627
middle aged (1607) 1607
efficacy (1568) 1568
doxorubicin (1554) 1554
studies (1543) 1543
biotechnology & applied microbiology (1541) 1541
biology (1495) 1495
melanoma (1476) 1476
lung cancer (1449) 1449
medical research (1428) 1428
antineoplastic agents (1423) 1423
rats (1411) 1411
flow cytometry (1397) 1397
clinical trials (1396) 1396
chemistry, multidisciplinary (1385) 1385
cell lines (1356) 1356
aged (1347) 1347
pharmacology (1346) 1346
carcinoma (1345) 1345
resistance (1345) 1345
phosphorylation (1340) 1340
physiological aspects (1334) 1334
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (29721) 29721
Japanese (60) 60
Chinese (57) 57
French (38) 38
German (27) 27
Russian (23) 23
Spanish (8) 8
Korean (7) 7
Polish (5) 5
Italian (3) 3
Portuguese (2) 2
Czech (1) 1
Hungarian (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 01/2018, Volume 359, Issue 6371, pp. 91 - 97
Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis induce sustained clinical responses in a sizable minority of cancer patients. We found that... 
CELL LUNG-CANCER | MELANOMA | MICROENVIRONMENT | INTESTINAL MICROBIOTA | CYCLOPHOSPHAMIDE | PD-1 BLOCKADE | MULTIDISCIPLINARY SCIENCES | GENES | RESISTANCE | ANTITUMOR IMMUNITY | NIVOLUMAB | CD4 Antigens - immunology | Immunotherapy - methods | Humans | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Gastrointestinal Microbiome - genetics | Fecal Microbiota Transplantation | Anti-Bacterial Agents - therapeutic use | Feces - microbiology | Metagenome - genetics | Neoplasms - therapy | Animals | Receptors, CCR - immunology | Interleukin-12 - immunology | Receptors, CXCR3 - immunology | T-Lymphocytes - immunology | Mice | Gastrointestinal Microbiome - immunology | Verrucomicrobia - genetics | Verrucomicrobia - immunology | Care and treatment | Cell receptors | Microbiota (Symbiotic organisms) | Immunotherapy | Epithelial tumors | Physiological aspects | Health aspects | Methods | Apoptosis | PD-1 protein | Interleukin | Microbiomes | Transplantation | Lymphocytes T | Anticancer properties | Microbiota | Lymphocytes | Bacteria | Feces | Supplementation | Gnotobiotics | Kidneys | Melanoma | Dietary supplements | Interleukin 12 | Abundance | CXCR3 protein | Patients | CD4 antigen | Immune checkpoint | Antibiotics | Lungs | Flora | PD-L1 protein | Relative abundance | Antitumor activity | CCR9 protein | Tumors | Kidney transplantation | Cancer | Life Sciences
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 02/2016, Volume 498, Issue 1-2, pp. 12 - 22
Journal Article
Science, ISSN 0036-8075, 01/2018, Volume 359, Issue 6371, pp. 104 - 108
Anti-PD-1-based immunotherapy has had a major impact on cancer treatment but has only benefited a subset of patients. Among the variables that could contribute... 
MULTIDISCIPLINARY SCIENCES | Immunotherapy - methods | Enterococcus faecium - immunology | Skin Neoplasms - immunology | Skin Neoplasms - therapy | Humans | Antibodies, Monoclonal - therapeutic use | Bifidobacterium longum - immunology | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Enterococcus faecium - genetics | Gastrointestinal Microbiome - genetics | Enterococcus faecium - isolation & purification | Bifidobacterium longum - genetics | Enterococcus faecium - classification | Feces - microbiology | Bifidobacterium longum - isolation & purification | Animals | Melanoma - immunology | Bifidobacterium longum - classification | RNA, Ribosomal, 16S - genetics | T-Lymphocytes - immunology | Mice | Gastrointestinal Microbiome - immunology | Melanoma - therapy | Care and treatment | Cell receptors | Microbiota (Symbiotic organisms) | Immunotherapy | Melanoma | Physiological aspects | Metastasis | Health aspects | Methods | Apoptosis | Animal models | rRNA 16S | PD-1 protein | Microbiomes | Lymphocytes T | Immunity | Metastases | Gene sequencing | Anticancer properties | Microorganisms | Bacteria | Supplementation | Gnotobiotics | Effectiveness | Kidneys | Dietary supplements | Ribonucleic acid--RNA | Patients | Polymerase chain reaction | Antibiotics | Lungs | Flora | PD-L1 protein | Antitumor activity | Cancer | Kidney transplantation
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2018, Volume 378, Issue 8, pp. 731 - 739
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2018, Volume 115, Issue 15, pp. 3912 - 3917
Journal Article
Journal Article